Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment
Se-Eun Kim, Byung-Su Yoo
Korean J Intern Med. 2025;40(3):357-370. Published online 2025 Apr 30 DOI: https://doi.org/10.3904/kjim.2024.387
Citations to this article as recorded by 
Dysphagia in heart failure: Demographics, nutritional status, and patient-reported outcomes
Juvel-Lou P. Velasco, Shenghao Xia, Shu-Fen Wung
Heart & Lung.2026; 78: 102724. CrossRef
From bench to bedside: adipose tissue fibrosis in obesity, anti-diabetic therapies, and bariatric surgery
Mihye Seo, Kyoil Suh, Hyeong Kyu Park, Kae Won Cho
The Korean Journal of Internal Medicine.2026; 41(2): 210. CrossRef
Tirzepatide in the management of heart failure with preserved ejection fraction: A narrative review
Meghna Bordoloi, Shilpa Bawankule, Sourya Acharya, Parth Aggarwal
Journal of Clinical Sciences.2026; 23(2): 112. CrossRef
AGONISTAS DO GLP-1 E INSUFICIÊNCIA CARDÍACA: EVIDÊNCIAS DA RELAÇÃO TERAPÊUTICA
Verônica Cristina Carvalho Chaves, Amanda Gêa Gomes Gonçalves, Gabriel Baiocchi Vieira Nascimento, Giovana Pezzini Backes, Maria Paula Maciel Bomtempo, Mireli Lacerda Borges, Pietra Santos Viana, Sarah Matias Moreira, Victor Hugo Oliveira Moraes
Revista Contemporânea.2026; 6(7): e10800. CrossRef
AGONISTAS DO GLP-1 E INSUFICIÊNCIA CARDÍACA: EVIDÊNCIAS DA RELAÇÃO TERAPÊUTICA
Verônica Cristina Carvalho Chaves, Amanda Gêa Gomes Gonçalves, Gabriel Baiocchi Vieira Nascimento, Giovana Pezzini Backes, Maria Paula Maciel Bomtempo, Mireli Lacerda Borges, Pietra Santos Viana, Sarah Matias Moreira, Victor Hugo Oliveira Moraes, Sofia de
REVISTA FOCO.2026; 19(7): e12162. CrossRef